Oral Wegovy Backed by CHMP at May Meeting

Oral Wegovy backed by CHMP at May meeting

The CHMP recommended eight new medicines and 13 line extensions at its May meeting, including Novo Nordisk's oral weight loss therapy.

Novo Nordisk’s Wegovy pill recommended for EU Approval

EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for the Wegovy pill. Already approved in the US, the pill has seen huge uptake, with more than 1 million people using it within the first 4 months of its launch. Developed by Novo Nordisk, it is intended for adults living with obesity, or those who are overweight and have at least one weight-related comorbidity, such as cardiovascular disease, hypertension, or t…